Cancer BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewed
BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer
Sushmitha Sriramulu, Shivani Thoidingjam, Wei‐Min Chen…·Shyam Nyati
This study identifies BUB1 as a regulator of non-homologous end joining (NHEJ) in triple-negative breast cancer (TNBC), showing that its inhibition sensitizes TNBC cells to radiotherapy.
22 citations